StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...

Warfarin Vs dabigatran - Essay Example

Cite this document
Summary
Warfarin vs. Dabigatran Subsequent utilization of the preferred anticoagulant Warfarin for more than five decades is currently confronted by many of its upcoming contenders providing hassle free monitoring. One of the strapping rival is Dabigatran, which has been approved by FDA on October 19, 2010 to treat Atrial fibrillation patients exhibiting enhanced risk of stroke and systemic embolisms (U.S…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER93.2% of users find it useful
Warfarin Vs dabigatran
Read Text Preview

Extract of sample "Warfarin Vs dabigatran"

Download file to see previous pages

Any discrepancy in diet mediated intensity of vitamin K, directly influences the efficacy and dose dependency of Warfarin for the patient. It is essential to determine appropriate therapeutic dosages on individual basis by means of standardized clotting test (international normalized ratio [INR]). Although, Warfarin potentially diminishes the risk of stroke in AF patients by ~ 68%, patient compliance with treatment (time in therapeutic range [TTR]) is a noteworthy predicament because of the essential periodic supervision of dose efficacy and the risk of major bleeding events (Ezekowitz, 2007).

On the contrary, Dabigatran does not entail labor and time intensive monitoring and therefore expected to provide enhanced patient compliance over Warfarin. Atrial fibrillation is asymptomatic and generally not life-threatening. It augments the risk of stroke as well as systemic embolisms as the upper chambers of the heart begin to beat irregularly, impairing the efficiency of blood flow. Symptoms found to be associated encompass rapid heart rate, palpitation, shortness of breath, dizziness, faint or fatigue.

Reduced flow of blood results in blood pooling in the heart chambers which may culminate into clot formation. When such clots enter the brain it results in stroke, it is therefore essential for physicians to prescribe anticoagulants to prevent formation of clots. The prevalence of AF in the United States display augmentation from < 1% for individuals under 60 and >10% for individuals above 80 (Centers for Disease Control and Prevention [CDC], 2003). Deaths associated to AF affect 1 in 4000 cases per year, of these, 84% cases are reported to be above 75.

Warfarin was drug of choice for past decades as an effective oral anticoagulant to prevent and treat thromboembolism. Over the years researchers were constantly trying to relieve patients from troubles related to diet and drug interactions. Three randomized, controlled trials are available on the safety and efficacy of Dabigatran, they are summarized below- Atrial fibrillation patients frequently suffer from coronary artery disease, which is the focus of a Dabigatran phase II clinical trial, to establish its safety in combination with aspirin (Ezekowitz et al., 2007). Three Dabigatran doses (50, 150, and 300 mg) were administered twice daily to patients for 12 weeks, unaided or in combination with 81 or 325 mg aspirin, thereby generating nine experimental groups.

The patients treated with Warfarin (INR = 2.0-3.0) were used as a control. The primary outcome of concern was bleeding events encompassing major (6% increase, p < 0.02) or all sorts of bleeding events (26% increase, p = 0.0003), that was reported in patients treated with 300 mg Dabigatran twice a day along with aspirin. On the other hand, 50 mg Dabigatran was less likely to cause bleeding as compared to other conditions (15% increase vs. 300 mg p = 0.0002; 11% increase vs. 150 mg p = 0.01; 11% increase vs.

Warfarin, p = 0.044). On the contrary, two embolisms reported in the study were from the cases taking 50 mg Dabigatran twice daily, unaided or accompanied by 81 mg aspirin. On the other hand result indicates that 50 mg Dabigatran, with or without 81 mg aspirin, does not accomplish successful shielding against stroke or systemic embolisms. This possibility was sustained by finding

...Download file to see next pages Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Warfarin Vs dabigatran Essay Example | Topics and Well Written Essays - 1250 words”, n.d.)
Retrieved from https://studentshare.org/family-consumer-science/1406913-warfarin-vs-dabigatran
(Warfarin Vs Dabigatran Essay Example | Topics and Well Written Essays - 1250 Words)
https://studentshare.org/family-consumer-science/1406913-warfarin-vs-dabigatran.
“Warfarin Vs Dabigatran Essay Example | Topics and Well Written Essays - 1250 Words”, n.d. https://studentshare.org/family-consumer-science/1406913-warfarin-vs-dabigatran.
  • Cited: 0 times

CHECK THESE SAMPLES OF Warfarin Vs dabigatran

Inpatient Anticoagulation

On the other hand, pradaxa inhibits thrombin, which is one of the blood… The generic name given to pradaxa is dabigatran.... The generic name given to pradaxa is dabigatran.... Fang (100) describes that researches conducted have shown that pradaxa reduces chances of one having blood clots and stroke unlike warfarin....
2 Pages (500 words) Essay

Dabigatran Etexilate's Destination

dabigatran etexilate is a competitive, reversible, direct thrombin inhibitor that is used for preventing strokes in those patients with atrial fibrillation.... dabigatran etexilate is taken as an oral drug.... Figure 2: Structure of the active molecule dabigatran.... dabigatran contains an ethyl group at the carboxylic acid and a side chain of hexyloxycarbonyl at the amidine.... dabigatran is a polar and charged molecule....
14 Pages (3500 words) Literature review

Warfarin Therapy Issues

In using the search question “how does warfarin therapy compare to other newer anticoagulants affect bleeding risks in older people in US,” another study was brought up that reflected a doctor's experience with newer drugs, dabigatran and rivaroxaban, that differ in many ways from warfarin, although dabigatran has some history of stomach distress (Schulman & Crowther, 2012).... This essay "warfarin Therapy Issues" dwells on how does warfarin therapy compared to other newer anti-coagulants, affect bleeding risks in older people in the United States....
2 Pages (500 words) Essay

How Efficient Are The Oral Anticoagulants Over Warfarin

On the other hand, the action new oral anticoagulants in the body; dabigatran, in this case, can be reversed using hemodialysis.... This method works to remove dabigatran from the body in 3 hours hence it can be used to treat dabigatran toxicity.... dabigatran, rivaroxaban, and apixaban are eliminated from the body through the renal system.... The paper "How Efficient Are The Oral Anticoagulants Over warfarin?...
4 Pages (1000 words) Assignment

Medical case study report

nticoagulationapixaban, dabigatran etexilate, rivaroxaban(all three contraindicated due to mitral valve replacement and valvular AF) or a vitamin K antagonist (warfarin) CHA2DS2-VASc score of 2 or above needs therapy [11]Therapy with warfarinCertain medicines are not suitable in certain conditions such as; cuts or wounds, Patient falls off relining chair at home.... mg/day, warfarin 10/11 night, Ezetrol 10mg evening, Vitamin D 2000IU Daily, Panadol osteo 2x665 mg PRN, Dutasterid 0....
1 Pages (250 words) Case Study

Causal Factors and Pathophysiology of Atrial Fibrillation

The disease involves the atria - the upper cardiac compartments.... During AF, electrical impulses of the sinoatrial node are suppressed by… As a result of this abnormal activity, irregular impulses reach the ventricles and produce irregular pulse.... In such a condition, heart pump works inefficiently, and tissues receive less blood, which may lead to a number of According to Bashore et al (2013), AF occurs in 10% of people above age 80....
8 Pages (2000 words) Research Paper

Anticoagulation Therapy for Stroke Prevention

From a therapeutic perspective, reports show that warfarin is the first line anticoagulant for patients with Atrial Fibrillation (Nice guideline 2012), especially when the condition is primary or severe because it curbs the development of stroke.... Moreover, warfarin has reduced rates of major gastrointestinal bleeding and myocardial infarction comparing with the novel oral anticoagulants (NHS Information Centre, 2014).... Despite its complete absorption after oral administration, warfarin is slow acting anticoagulant with a long half-life....
7 Pages (1750 words) Case Study

The Use of the Drug Warfarin in Treatment of Diseases and Illnesses Affecting the Cardiovascular System

This paper "The Use of the Drug warfarin in Treatment of Diseases and Illnesses Affecting the Cardiovascular System" focuses on the fact that the cardiovascular system manifests several diseases and illnesses, some of which are more prevalent than others.... warfarin is an anticoagulant drug and is currently the most widely used in treating diseases of the cardiovascular system.... The main objectives of the research are: to study the action of the drug warfarin, to analyse and evaluate the role of warfarin in the treatment of diseases and illnesses affecting the cardiovascular system, and survey new research developments in oral anticoagulants in which bleeding risks will be less....
24 Pages (6000 words) Case Study
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us